Position in EXEL
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$3,817,405
+$3,014,505 QoQ
Shares Held
70,160
+274.8% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#197
of 751 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $59,653,938 across 287 Biotechnology names. EXEL ranks #4 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
118,402 | $13,422,050 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,563 | $5,962,913 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,844 | $4,167,459 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
70,160 | $3,817,405 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
66,469 | $2,592,955 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,662 | $2,315,755 | |
| 7 | MESO |
Mesoblast Ltd
|
168,022 | $2,273,337 | |
| 8 | FTRE |
Fortrea Holdings Inc.
|
88,116 | $1,533,218 |
All Filings in EXEL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,817,405 | 70,160 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $802,900 | 18,720 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $586,708 | 13,386 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,806,582 | 67,956 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $619,588 | 14,056 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $93,149 | 2,523 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $37,629 | 1,130 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $29,323 | 1,130 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $20,537 | 914 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $13,051 | 550 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $13,194 | 550 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $12,017 | 550 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,510 | 550 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $10,675 | 550 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $8,822 | 550 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $8,624 | 550 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $11,451 | 550 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $12,468 | 550 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $10,054 | 550 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $11,627 | 550 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $10,021 | 550 | Shares | Sole | 2021-08-02 | |
| 2020-12-31 | $11,038 | 550 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $13,447 | 550 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $13,057 | 550 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $4,735 | 275 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||